Streetbeat News

Stock Prices

BROG

Brooge Energy's shares are trading lower despite the recent acquisition proposal by Gulf Navigation Holdings. The stock had gained on Wednesday following the announcement of the proposal.

Portfolio Pulse from Bill Haddad

October 05, 2023 | 4:09 pm

GRAM

STHZF

Z&A's latest report explores the retail landscape of the cannabis market in California, highlighting significant revenue variations among counties. The report also notes that the size of retail operations and strategic location are crucial for success. The California cannabis market experienced an 11% YoY drop in 3Q23, followed by a 6% sequential decline. However, sales appear to be stabilizing after a surge in 2021. The report also mentions StateHouse (OTC:STHZF) and Gold Flora (OTC:GRAM), suggesting that with the right strategies, these companies could achieve impressive revenue per store figures.

Portfolio Pulse from Nicolás Jose Rodriguez

October 05, 2023 | 4:08 pm

NBTX

Nanobiotix announced the presentation of a final efficacy analysis from the Phase 1 cohort expansion evaluating NBTXR3 in locally advanced head and neck cancer. Following the announcement, the company's shares are trading lower.

Portfolio Pulse from Bill Haddad

October 05, 2023 | 4:05 pm

CDNS

The article provides a comprehensive comparison of Cadence Design Systems (NASDAQ:CDNS) with its competitors in the Software industry. The analysis includes financial metrics, market position, and growth prospects. Cadence Design Systems has a lower PE ratio than the industry average, suggesting it may be undervalued. However, its high PB and PS ratios suggest potential overvaluation relative to its book value and sales. The company has a higher ROE, indicating strong returns on shareholder equity, but lower EBITDA, gross profit, and revenue growth, suggesting potential profitability and revenue generation challenges.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 4:01 pm

ACRV

Analysts have provided bullish ratings for Acrivon Therapeutics (NASDAQ:ACRV) within the last quarter. These 4 analysts have an average price target of $22.5 versus the current price of Acrivon Therapeutics at $8.78, implying upside. This average price target has increased by 7.14% over the past month.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 4:00 pm

HD

Home Depot (NYSE:HD) has outperformed the market over the past 20 years, producing an average annual return of 11.13%. If an investor had bought $1000 of HD stock 20 years ago, it would be worth $8,207.04 today.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 4:00 pm

WEC

Analysts have provided various ratings for WEC Energy Group (NYSE:WEC) within the last quarter, with 3 somewhat bullish, 6 indifferent, and 1 somewhat bearish. The company has an average price target of $93.3, a decrease of 5.89% from the previous average price target of $99.14.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 4:00 pm

FMX

Fomento Economico (NYSE:FMX) has outperformed the market over the past 20 years by 4.13% on an annualized basis, producing an average annual return of 11.32%. If an investor had bought $1000 of FMX stock 20 years ago, it would be worth $8,485.09 today.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 4:00 pm

BNTX

A comparative study of BioNTech (NASDAQ:BNTX) and its competitors in the biotechnology industry reveals that BioNTech's stock may be undervalued based on its low Price to Earnings (PE), Price to Book (PB), and Price to Sales (PS) ratios. However, the company's financial performance is relatively weak compared to its industry peers, as indicated by its low Return on Equity (ROE), Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), gross profit, and revenue growth ratios.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 4:00 pm

RPM

Analysts have provided ratings for RPM Intl (NYSE:RPM) within the last quarter, with 1 bullish, 3 somewhat bullish, and 1 indifferent. The average price target is $114.8, implying an upside from the current price of $98.61. This average has increased by 18.6% from the previous average price target of $96.80.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 4:00 pm